(Q43775656)

English

From trial and error to trial simulation. Part 2: an appraisal of current beliefs in the design and analysis of clinical trials for antidepressant drugs

scientific article published on 12 August 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

From trial and error to trial simulation. Part 2: an appraisal of current beliefs in the design and analysis of clinical trials for antidepressant drugs (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

G Santen

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

J Horrigan

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

M Danhof

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

O Della Pasqua

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

12 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

255-262

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

21 January 2018

Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

21 January 2018

Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

21 January 2018

Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

21 January 2018

Clinical trials and the response rate illusion

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

21 January 2018

Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

21 January 2018

Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

21 January 2018

Why do we need new and better antidepressants?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

21 January 2018

The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

21 January 2018

Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

21 January 2018

Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of the metabolism and pharmacokinetics of paroxetine in man.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

7 January 2021

based on heuristic

inferred from DOI database lookup

Innovation and placebos in research: a new design of clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.107

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2009.107

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43775656&oldid=2103223831"